• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

用于肝细胞癌预后评估的MRI成像生物标志物

MRI Imaging Biomarkers for Prognostication of Hepatocellular Carcinoma.

作者信息

Yoon Ja Kyung, Choi Jin-Young

出版信息

J Korean Soc Radiol. 2025 May;86(3):364-380. doi: 10.3348/jksr.2025.0029. Epub 2025 May 28.

DOI:10.3348/jksr.2025.0029
PMID:40502476
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12149881/
Abstract

Hepatocellular carcinoma (HCC) is a heterogeneous tumor with variable prognosis, even among patients at a similar tumor stage. Therefore, identifying prognostic features prior to treatment can help select the best therapeutic approach and ultimately optimize patient survival. While many imaging features on MRI have been suggested to have prognostic potential, some have emerged as critical imaging biomarkers, and efforts are underway to define and standardize relevant terminology. In this article, we comprehensively review MRI imaging features of HCC with prognostic potential.

摘要

肝细胞癌（HCC）是一种异质性肿瘤，预后各不相同，即使在肿瘤分期相似的患者中也是如此。因此，在治疗前识别预后特征有助于选择最佳治疗方法，并最终优化患者的生存率。虽然已有许多MRI上的影像特征被认为具有预后潜力，但其中一些已成为关键的影像生物标志物，目前正在努力定义和规范相关术语。在本文中，我们全面回顾了具有预后潜力的HCC的MRI影像特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/994a/12149881/d29c0507b2da/jksr-86-364-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/994a/12149881/5f010d2ab2d3/jksr-86-364-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/994a/12149881/5d45a03e1bcb/jksr-86-364-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/994a/12149881/706d3d22336e/jksr-86-364-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/994a/12149881/7828ba46e000/jksr-86-364-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/994a/12149881/2c15fb504a83/jksr-86-364-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/994a/12149881/d29c0507b2da/jksr-86-364-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/994a/12149881/5f010d2ab2d3/jksr-86-364-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/994a/12149881/5d45a03e1bcb/jksr-86-364-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/994a/12149881/706d3d22336e/jksr-86-364-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/994a/12149881/7828ba46e000/jksr-86-364-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/994a/12149881/2c15fb504a83/jksr-86-364-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/994a/12149881/d29c0507b2da/jksr-86-364-g006.jpg

相似文献

1
MRI Imaging Biomarkers for Prognostication of Hepatocellular Carcinoma.用于肝细胞癌预后评估的MRI成像生物标志物
J Korean Soc Radiol. 2025 May;86(3):364-380. doi: 10.3348/jksr.2025.0029. Epub 2025 May 28.
2
Prognostic implications of CT/MRI LI-RADS in hepatocellular carcinoma: State of the art and future directions.CT/MRI LI-RADS 在肝细胞癌中的预后意义：现状与未来方向。
Liver Int. 2022 Oct;42(10):2131-2144. doi: 10.1111/liv.15362. Epub 2022 Jul 25.
3
Magnetic resonance imaging for treatment response evaluation and prognostication of hepatocellular carcinoma after thermal ablation.磁共振成像用于热消融后肝细胞癌治疗反应评估及预后判断
Insights Imaging. 2023 May 16;14(1):87. doi: 10.1186/s13244-023-01440-7.
4
MRI imaging features for predicting macrotrabecular-massive subtype hepatocellular carcinoma: a systematic review and meta-analysis.MRI 成像特征预测巨梁型-块状型肝细胞癌：系统评价和荟萃分析。
Eur Radiol. 2024 Oct;34(10):6896-6907. doi: 10.1007/s00330-024-10671-1. Epub 2024 Mar 20.
5
Intraindividual comparison of CT and MRI for predicting vessels encapsulating tumor clusters in hepatocellular carcinoma.CT与MRI在预测肝细胞癌中包裹肿瘤簇的血管方面的个体内比较。
Eur Radiol. 2025 Jan;35(1):61-72. doi: 10.1007/s00330-024-10944-9. Epub 2024 Jul 12.
6
Evaluation and Prognostication of Gd-EOB-DTPA MRI and CT in Patients With Macrotrabecular-Massive Hepatocellular Carcinoma.钆塞酸二钠增强 MRI 和 CT 在巨梁型/巨块型肝细胞癌患者中的评估与预后价值
J Magn Reson Imaging. 2024 Jun;59(6):2071-2081. doi: 10.1002/jmri.29052. Epub 2023 Oct 15.
7
Prognostic role of magnetic resonance imaging vs. computed tomography for hepatocellular carcinoma undergoing chemoembolization.磁共振成像与计算机断层扫描在接受化疗栓塞的肝细胞癌中的预后作用
Liver Int. 2015 Jun;35(6):1722-30. doi: 10.1111/liv.12751. Epub 2015 Jan 21.
8
Updating the Clinical Application of Blood Biomarkers and Their Algorithms in the Diagnosis and Surveillance of Hepatocellular Carcinoma: A Critical Review.更新血液生物标志物及其算法在肝细胞癌诊断和监测中的临床应用：批判性评价。
Int J Mol Sci. 2023 Feb 21;24(5):4286. doi: 10.3390/ijms24054286.
9
Gadoxetic acid-enhanced MRI of macrotrabecular-massive hepatocellular carcinoma and its prognostic implications.钆塞酸二钠增强磁共振成像对巨小梁型-大块型肝细胞癌的诊断及其预后意义
J Hepatol. 2021 Jan;74(1):109-121. doi: 10.1016/j.jhep.2020.08.013. Epub 2020 Aug 18.
10
Prognostication of Hepatocellular Carcinoma Using Artificial Intelligence.利用人工智能预测肝细胞癌。
Korean J Radiol. 2024 Jun;25(6):550-558. doi: 10.3348/kjr.2024.0070.

本文引用的文献

1
Deep learning radiomics based on contrast enhanced MRI for preoperatively predicting early recurrence in hepatocellular carcinoma after curative resection.基于对比增强磁共振成像的深度学习影像组学在术前预测肝细胞癌根治性切除术后早期复发中的应用
Front Oncol. 2024 Nov 8;14:1446386. doi: 10.3389/fonc.2024.1446386. eCollection 2024.
2
Intraindividual comparison of prognostic imaging features of HCCs between MRIs with extracellular and hepatobiliary contrast agents.肝细胞癌在使用细胞外对比剂和肝胆对比剂的磁共振成像之间的预后影像特征的个体内比较。
Liver Int. 2024 Oct;44(10):2847-2857. doi: 10.1111/liv.16059. Epub 2024 Aug 6.
3
Prognostication of Hepatocellular Carcinoma Using Artificial Intelligence.
利用人工智能预测肝细胞癌。
Korean J Radiol. 2024 Jun;25(6):550-558. doi: 10.3348/kjr.2024.0070.
4
Heterogeneity of hepatocellular carcinoma: from mechanisms to clinical implications.肝细胞癌的异质性：从机制到临床意义。
Cancer Gene Ther. 2024 Aug;31(8):1105-1112. doi: 10.1038/s41417-024-00764-w. Epub 2024 Mar 18.
5
Imaging prognostication and tumor biology in hepatocellular carcinoma.肝细胞癌的影像学预后评估与肿瘤生物学
J Liver Cancer. 2023 Sep;23(2):284-299. doi: 10.17998/jlc.2023.08.29. Epub 2023 Sep 15.
6
MRI-Based Radiomics and Deep Learning in Biological Characteristics and Prognosis of Hepatocellular Carcinoma: Opportunities and Challenges.基于 MRI 的放射组学和深度学习在肝细胞癌生物学特征和预后中的应用：机遇与挑战。
J Magn Reson Imaging. 2024 Mar;59(3):767-783. doi: 10.1002/jmri.28982. Epub 2023 Aug 30.
7
Radiologic features of hepatocellular carcinoma related to prognosis.肝细胞癌的放射学特征与预后的关系
J Liver Cancer. 2023 Mar;23(1):143-156. doi: 10.17998/jlc.2023.02.16. Epub 2023 Mar 9.
8
The Hong Kong consensus statements on unresectable hepatocellular carcinoma: narrative review and update for 2021.《香港不可切除肝细胞癌共识声明：2021年叙述性综述与更新》
Hepatobiliary Surg Nutr. 2023 Jun 1;12(3):366-385. doi: 10.21037/hbsn-21-405. Epub 2023 May 6.
9
AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma.美国肝病研究学会肝细胞癌预防、诊断和治疗实践指南。
Hepatology. 2023 Dec 1;78(6):1922-1965. doi: 10.1097/HEP.0000000000000466. Epub 2023 May 22.
10
Three-dimensional multifrequency magnetic resonance elastography improves preoperative assessment of proliferative hepatocellular carcinoma.三维多频磁共振弹性成像改善增殖性肝细胞癌的术前评估。
Insights Imaging. 2023 May 18;14(1):89. doi: 10.1186/s13244-023-01427-4.